Literature DB >> 18378436

Adhesion and protease activity in cell lines from human salivary gland tumors are regulated by the laminin-derived peptide AG73, syndecan-1 and beta1 integrin.

Letícia N Gama-de-Souza1, Elaine Cyreno-Oliveira, Vanessa M Freitas, Edielle S Melo, Vanessa F Vilas-Boas, Anselmo S Moriscot, Ruy G Jaeger.   

Abstract

We studied the induction of protease activity by the laminin alpha1-derived peptide AG73 in cells from adenoid cystic carcinoma (CAC2) and myoepithelioma (M1), respectively a malignant and a benign salivary gland tumors. Laminin alpha1 chain and MMP9 were immunolocalized in adenoid cystic carcinoma and myoepithelioma in vivo and in vitro. Cells grown inside AG73-enriched laminin-111 exhibited large spaces in the extracellular matrix, suggestive of remodeling. The broad spectrum MMP inhibitor GM6001 decreased spaces induced by AG73 in CAC2 and M1 cells. This result strongly suggests that AG73-mediated matrix remodeling involves matrix metalloproteinases. CAC2 and M1 cells cultured on AG73 showed a dose-dependent increase of MMP9 secretion, as detected by zymography. Furthermore, siRNA silencing of MMP9 decreased remodeling in 3D cultures. We searched for AG73 receptors regulating MMP9 activity in our cell lines. CAC2 and M1 cells grown on AG73 exhibited colocalization of syndecan-1 and beta1 integrin. siRNA knockdown of syndecan-1 expression in these cells resulted in decreased adhesion to AG73 and reduced protease and remodeling activity. We investigated syndecan-1 co-receptors in both cell lines. Silencing beta1 integrin inhibited adhesion to AG73, matrix remodeling and protease activity. Double-knockdown experiments were carried out to further explore syndecan-1 and beta1 integrin cooperation. CAC2 cells transfected with both syndecan-1 and beta1 integrin siRNA oligos showed significant decrease in adhesion to AG73. Simultaneous silencing of receptors also induced a decrease in protease activity. Our results suggest that syndecan-1 and beta1 integrin signaling downstream of AG73 regulate adhesion and MMP production by CAC2 and M1 cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18378436     DOI: 10.1016/j.matbio.2008.02.007

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  6 in total

Review 1.  Molecular functions of syndecan-1 in disease.

Authors:  Yvonne Hui-Fang Teng; Rafael S Aquino; Pyong Woo Park
Journal:  Matrix Biol       Date:  2011-10-18       Impact factor: 11.583

2.  Laminin-derived peptide AG73 regulates migration, invasion, and protease activity of human oral squamous cell carcinoma cells through syndecan-1 and beta1 integrin.

Authors:  Adriane S Siqueira; Letícia N Gama-de-Souza; Maria Vanda C Arnaud; João J V Pinheiro; Ruy G Jaeger
Journal:  Tumour Biol       Date:  2009-12-09

3.  Laminin-111 peptide C16 regulates invadopodia activity of malignant cells through β1 integrin, Src and ERK 1/2.

Authors:  Adriane S Siqueira; Monique P Pinto; Mário C Cruz; Basilio Smuczek; Karen S P Cruz; José Alexandre M Barbuto; Daisuke Hoshino; Alissa M Weaver; Vanessa M Freitas; Ruy G Jaeger
Journal:  Oncotarget       Date:  2016-07-26

4.  The Laminin-α1 Chain-Derived Peptide, AG73, Binds to Syndecans on MDA-231 Breast Cancer Cells and Alters Filopodium Formation.

Authors:  Madhavi Puchalapalli; Liang Mu; Chevaunne Edwards; Benjamin Kaplan-Singer; Pearl Eni; Kiran Belani; David Finkelstein; Arpan Patel; Megan Sayyad; Jennifer E Koblinski
Journal:  Anal Cell Pathol (Amst)       Date:  2019-04-30       Impact factor: 2.916

Review 5.  Laminin-111-derived peptides and cancer.

Authors:  Yamato Kikkawa; Kentaro Hozumi; Fumihiko Katagiri; Motoyoshi Nomizu; Hynda K Kleinman; Jennifer E Koblinski
Journal:  Cell Adh Migr       Date:  2012-12-21       Impact factor: 3.405

6.  Stromal and epithelial syndecan-1 expression in benign and malignant salivary gland tumors: which is more reflective of behavior?

Authors:  Mojgan Alaeddini; Farzad Yazdani; Shahroo Etemad-Moghadam
Journal:  Braz J Otorhinolaryngol       Date:  2019-09-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.